{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T19:56:43Z","timestamp":1696276603482},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/mph.0000000000000294","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T13:41:12Z","timestamp":1418218872000},"page":"409-410","source":"Crossref","is-referenced-by-count":2,"title":["Heart Transplantation in the Short Term After Chemotherapy"],"prefix":"10.1097","volume":"37","author":[{"given":"Kenneth R.","family":"Knecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiomara","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry","family":"Pye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parthak","family":"Prodhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210209","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.healun.2012.11.003","article-title":". Pre-transplant malignancy: an analysis of outcomes after thoracic organ transplantation.","volume":"32","author":"Beaty","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R2-14-20210209","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.healun.2014.01.862","article-title":". A multi-institutional study of malignancies after heart transplantation and a comparison with the general United States population.","volume":"33","author":"Higgins","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R3-14-20210209","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.healun.2012.03.018","article-title":". Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation.","volume":"31","author":"Oliveira","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R4-14-20210209","first-page":"461","article-title":"Long-term immunosuppression and malignancy in thoracic transplantation: wheres the balance J Heart Lung Transplant.","volume":"33","author":"Nair","year":"2014","journal-title":""},{"key":"R5-14-20210209","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/pbc.21105","article-title":". Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.","volume":"48","author":"Creutzig","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R6-14-20210209","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1124\/dmd.110.035550","article-title":". Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down Syndrome.","volume":"38","author":"Kalabus","year":"2010","journal-title":"Drug Metab Depos"},{"key":"R7-14-20210209","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1200\/JCO.2007.13.2209","article-title":". Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Childrens Oncology Group Study POG 9421.","volume":"26","author":"OBrien","year":"2008","journal-title":"J Clin Oncol"},{"key":"R8-14-20210209","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1200\/JCO.1997.15.4.1544","article-title":". Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience.","volume":"15","author":"Krischer","year":"1997","journal-title":"J Clin Oncol"},{"key":"R9-14-20210209","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/ehm.10.14","article-title":"Unique clinical and biological features of leukemia in Down syndrome children.","volume":"3","author":"Xavier","year":"2010","journal-title":"Exp Rev Hematol"},{"key":"R10-14-20210209","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/S0041-1345(03)00453-6","article-title":". Heart transplantation in chemotherapeutic dilated cardiomyopathy.","volume":"35","author":"Grande","year":"2003","journal-title":"Transplant Proc"},{"key":"R11-14-20210209","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2003.08.060","article-title":". Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Childrens Cancer Group Study 2891.","volume":"21","author":"Gamis","year":"2003","journal-title":"J Clin Oncol"},{"key":"R12-14-20210209","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/pbc.20207","article-title":"Acute myeloid leukemia and Down syndrome evolution of modern therapy.","volume":"44","author":"Gamis","year":"2005","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:46:18Z","timestamp":1620963978000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201507000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000294","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}